Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly To Cease Development Of Alzheimer's Drug

Sep 01 2010

Related Content

Alzheimer's Development Financing: Risky Therapies Call for Innovative Deals

Sep 01 2008

Pharma's Strategic Divide: Focus or Diversify

Sep 01 2008

Without Strattera, Will Lilly Merge?

Aug 13 2010

Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads

Jul 01 2010

Lilly Tries to Buy Time

Dec 01 2009

Related Companies

Eli Lilly and Company

Pfizer Inc.

Johnson & Johnson

Bristol Myers Squibb Company

Elan Corporation

Satori Pharmaceuticals, Inc.

Medivation, Inc.

Myriad Genetics, Inc.

H. Lundbeck A/S

IQVIA Holdings Inc.

Bristol Myers Squibb Company

Alkermes plc

ICOS Corporation

GSK plc

Sanofi

Novartis AG

Additional Topics

BioPharmaceutical

More from In Vivo Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.